Increased translation driven by non-canonical EZH2 creates a synthetic vulnerability in enzalutamide-resistant prostate cancer

Shankha Subhra Chatterjee(Cornell University), María T. Diaz‐Meco(University of Cincinnati Medical Center)
Nature Communications
November 20, 2024
Cited by 12


Related Papers